BACKGROUND: LACTB was recently identified as a mitochondrial tumour suppressor that negatively affects cancer cell proliferation by inducing cell death and/or differentiation, depending on the cell type and tissue. However, the detailed mechanism underlying the LACTB-induced cancer cell death is largely unknown. METHODS: We used cell-based, either in 2D or 3D conditions, and in vivo experiments to understand the LACTB mechanisms. In this regard, protein array followed by an enrichment analysis, cell proliferation assays using different compounds, western blot analysis, flow cytometry and immunofluorescence were performed. Differences between quantitative variables following normal distribution were valuated using Student t test for paired or no-paired samples according to the experiment. For in vivo experiments differences in tumour growth were analyzed by 2-way ANOVA. RESULTS: We show, that LACTB expression leads to cell cycle arrest in G1 phase and increase of DNA oxidation that leads to activation of intrinsic caspase-independent cell death pathway. This is achieved by an increase of mitochondrial reactive oxygen species since early time points of LACTB induction. CONCLUSION: Our work provides a deeper mechanistic insight into LACTB-mediated cancer-cell death and shows the dynamics of the cellular responses a particular tumor suppressive stimulus might evoke under different genetic landscapes.

Department of Cell Biology Faculty of Science Charles University Prague Czech Republic

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic

The Czech Center for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic

Zobrazit více v PubMed

Kontomanolis EN, Koutras A, Syllaios A, et al. Role of oncogenes and tumor-suppressor genes in carcinogenesis: A review. Anticancer Res. 2020 doi: 10.21873/anticanres.14622. PubMed DOI

Keckesova Z, Donaher JL, De Cock J, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681–686. doi: 10.1038/nature21408. PubMed DOI PMC

Polianskyte Z, Peitsaro N, Dapkunas A, et al. LACTB is a filament-forming protein localized in mitochondria. Proc Natl Acad Sci U S A. 2009;106:18960–18965. doi: 10.1073/pnas.0906734106. PubMed DOI PMC

Yang F, Yan Z, Nie W, Cheng X, Liu Z, Wang W, Shao C, Fu G, Yu Y. LACTB induced apoptosis of oxaliplatin-resistant gastric cancer through regulating autophagy-mediated mitochondrial apoptosis pathway. Am J Transl Res. 2021;13:601–616. PubMed PMC

Liu J, Yang L, Yuan X, Xiong M, Zhu J, Wu W, Ren M, Long J, Xu X, Gou M. Targeted nanotherapeutics using lactb gene therapy against melanoma. Int J Nanomedicine. 2021;16:7697–7709. doi: 10.2147/IJN.S331519. PubMed DOI PMC

Xue C, He Y, Zhu W, et al. Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma. Am J Transl Res. 2018;10:4152–4162. PubMed PMC

Xu W, Yu M, Qin J, Luo Y, Zhong M. LACTB regulates PIK3R3 to promote autophagy and inhibit EMT and proliferation through the PI3K/AKT/mTOR signaling pathway in colorectal cancer. Cancer Manag Res. 2020;12:5181–5200. doi: 10.2147/CMAR.S250661. PubMed DOI PMC

Ma Y, Wang L, He F, Yang J, Ding Y, Ge S, Fan X, Zhou Y, Xu X, Jia R. LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction. Cancer Lett. 2021;506:67–82. doi: 10.1016/j.canlet.2021.02.022. PubMed DOI

Li HT, Dong DY, Liu Q, Xu YQ, Chen L. Overexpression of LACTB, a mitochondrial protein that inhibits proliferation and invasion in glioma cells. Oncol Res. 2019;27:423–429. doi: 10.3727/096504017X15030178624579. PubMed DOI PMC

Zeng K, Chen X, Hu X, Liu X, Xu T, Sun H, Pan Y, He B, Wang S. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Oncogene. 2018;37:5534–5551. doi: 10.1038/s41388-018-0352-7. PubMed DOI

Elmore S. Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol. 2007;35:495–516. doi: 10.1080/01926230701320337. PubMed DOI PMC

Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395–417. doi: 10.1038/s41571-020-0341-y. PubMed DOI PMC

Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87:99–163. doi: 10.1152/physrev.00013.2006. PubMed DOI

Bano D, Prehn JHM. Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer. EBioMedicine. 2018;30:29–37. doi: 10.1016/j.ebiom.2018.03.016. PubMed DOI PMC

Mani SA, Guo W, Liao MJ, et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell. 2008;133:704–715. doi: 10.1016/j.cell.2008.03.027. PubMed DOI PMC

Broaddus VC, Dansen TB, Abayasiriwardana KS, Wilson SM, Finch AJ, Swigart LB, Hunt AE, Evan GI. Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage. J Biol Chem. 2005;280:12486–12493. doi: 10.1074/jbc.M408190200. PubMed DOI

Jänicke RU. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat. 2009;117:219–221. doi: 10.1007/s10549-008-0217-9. PubMed DOI

Kagawa S, Gu J, Honda T, McDonnell TJ, Swisher SG, Roth JA, Fang B. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin Cancer Res. 2001;7:1474–1480. PubMed

Mc Gee MM, Hyland E, Campiani G, Ramunno A, Nacci V, Zisterer DM. Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6. FEBS Lett. 2002;515:66–70. doi: 10.1016/S0014-5793(02)02440-7. PubMed DOI

Cortes CL, Veiga SR, Almacellas E, Hernández-Losa J, Ferreres JC, Kozma SC, Ambrosio S, Thomas G, Tauler A. Effect of low doses of actinomycin D on neuroblastoma cell lines. Mol Cancer. 2016;15:1–13. doi: 10.1186/s12943-015-0489-8. PubMed DOI PMC

Yang S, Zhou Q, Yang X. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta - Mol Cell Res. 2007;1773:903–911. doi: 10.1016/j.bbamcr.2007.03.021. PubMed DOI

Westphal D, Kluck RM, Dewson G. Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ. 2014;21:196–205. doi: 10.1038/cdd.2013.139. PubMed DOI PMC

Uren RT, Iyer S, Kluck RM. Pore formation by dimeric Bak and Bax: an unusual pore? Philos Trans R Soc Lond B Biol Sci. 2017;372:20160218. doi: 10.1098/rstb.2016.0218. PubMed DOI PMC

Ortega MA, Fraile-Martínez O, Asúnsolo Á, Buján J, García-Honduvilla N, Coca S (2020) Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR. J Oncol 2020:9258396 PubMed PMC

Yin P, Wang W, Zhang Z, Bai Y, Gao J, Zhao C. Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists. Cancer Sci. 2018;109:3368–3375. doi: 10.1111/cas.13771. PubMed DOI PMC

Xu X, Zhang M, Xu F, Jiang S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol Cancer. 2020;19:165. doi: 10.1186/s12943-020-01276-5. PubMed DOI PMC

Sarkar DK, Jana D, Patil PS, Chaudhari KS, Chattopadhyay BK, Chikkala BR, Mandal S, Chowdhary P. Role of NF-κB as a Prognostic Marker in Breast Cancer: A Pilot Study in Indian Patients. Indian J Surg Oncol. 2013;4:242–247. doi: 10.1007/s13193-013-0234-y. PubMed DOI PMC

Qian KBD, Shanon S, Ian B, Sankar S, PA GB, Dirk IJ. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci. 2004;101:10137–10142. doi: 10.1073/pnas.0403621101. PubMed DOI PMC

Giampazolias E, Zunino B, Dhayade S, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116–1129. doi: 10.1038/ncb3596. PubMed DOI PMC

Jakoube P, Cutano V, Gonzalez-Morena JM, Keckesova Z (2021) Mitochondrial tumor suppressors - the energetic enemies of tumor progression.Cancer Res canres.0518.2021 PubMed PMC

Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48:158–167. doi: 10.1016/j.molcel.2012.09.025. PubMed DOI PMC

Bigarella CL, Liang R, Ghaffari S. Stem cells and the impact of ROS signaling. Dev. 2014;141:4206–4218. doi: 10.1242/dev.107086. PubMed DOI PMC

Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122:877–902. doi: 10.1161/CIRCRESAHA.117.311401. PubMed DOI PMC

Mitra S, Boldogh I, Izumi T, Hazra TK. Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environ Mol Mutagen. 2001;38:180–190. doi: 10.1002/em.1070. PubMed DOI PMC

Zhang XP, Liu F, Wang W. Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage. J Biol Chem. 2010;285:31571–31580. doi: 10.1074/jbc.M110.134650. PubMed DOI PMC

Tadic V, Prell T, Lautenschlaeger J, Grosskreutz J. The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front Cell Neurosci. 2014;8:147. doi: 10.3389/fncel.2014.00147. PubMed DOI PMC

Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014;21:396–413. doi: 10.1089/ars.2014.5851. PubMed DOI PMC

Bertero E, Maack C. Calcium Signaling and Reactive Oxygen Species in Mitochondria. Circ Res. 2018;122:1460–1478. doi: 10.1161/CIRCRESAHA.118.310082. PubMed DOI

Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion*. J Biol Chem. 2001;276:30724–30728. doi: 10.1074/jbc.M103701200. PubMed DOI

Roucou X, Montessuit S, Antonsson B, Martinou J-C. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J. 2002;368:915–921. doi: 10.1042/bj20020972. PubMed DOI PMC

Morciano G, Naumova N, Koprowski P, Valente S, Sard VA, Potes Y, Rimessi A, Wieckowski MR, Oliveira PJ (2021) The mitochondrial permeability transition pore: an evolving concept critical for cell life and death. 10.1111/brv.12764 PubMed

Mironova GD, Pavlov EV. Mitochondrial cyclosporine a-independent palmitate/ca2+-induced permeability transition pore (Pa-mpt pore) and its role in mitochondrial function and protection against calcium overload and glutamate toxicity. Cells. 2021;10:1–17. doi: 10.3390/cells10010125. PubMed DOI PMC

Helton ES, Chen X. p53 modulation of the DNA damage response. J Cell Biochem. 2007;100:883–896. doi: 10.1002/jcb.21091. PubMed DOI

Liu X, Salokas K, Tamene F, Jiu Y, Weldatsadik RG, Öhman T, Varjosalo M. An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations. Nat Commun. 2018 doi: 10.1038/s41467-018-03523-2. PubMed DOI PMC

Botham A, Coyaud E, Nirmalanandhan VS, et al. Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2. Proteomics. 2019;19:1–10. doi: 10.1002/pmic.201900139. PubMed DOI

Sherman MH, Bassing CH, Teitell MA. Regulation of cell differentiation by the DNA damage response. Trends Cell Biol. 2011;21:312–319. doi: 10.1016/j.tcb.2011.01.004. PubMed DOI PMC

Pashkovskaia N, Gey U, Rödel G. Mitochondrial ROS direct the differentiation of murine pluripotent P19 cells. Stem Cell Res. 2018;30:180–191. doi: 10.1016/j.scr.2018.06.007. PubMed DOI

Ruijtenberg S, van den Heuvel S. Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle. 2016;15:196–212. doi: 10.1080/15384101.2015.1120925. PubMed DOI PMC

Myster DL, Duronio RJ. Cell cycle: To differentiate or not to differentiate? Curr Biol. 2000;10:R302–R304. doi: 10.1016/S0960-9822(00)00435-8. PubMed DOI

Kumar V, Chauhan SS. Daidzein Induces Intrinsic Pathway of Apoptosis along with ER α/β Ratio Alteration and ROS Production. Asian Pac J Cancer Prev. 2021;22:603. doi: 10.31557/APJCP.2021.22.2.603. PubMed DOI PMC

Etti IC, Rasedee A, Mohd Hashim N, Abdul AB, Kadir A, Yeap SK, Waziri P, Malami I, Lim KL, Etti CJ. Artonin E induces p53-independent G1 cell cycle arrest and apoptosis through ROS-mediated mitochondrial pathway and livin suppression in MCF-7 cells. Drug Des Devel Ther. 2017;11:865. doi: 10.2147/DDDT.S124324. PubMed DOI PMC

Koul M, Kumar A, Deshidi R, Sharma V, Singh RD, Singh J, Sharma PR, Shah BA, Jaglan S, Singh S. Cladosporol A triggers apoptosis sensitivity by ROS-mediated autophagic flux in human breast cancer cells. BMC Cell Biol. 2017;18:1–15. PubMed PMC

Foo JB, Yazan LS, Tor YS, Armania N, Ismail N, Imam MU, Yeap SK, Cheah YK, Abdullah R, Ismail M. Induction of cell cycle arrest and apoptosis in caspase-3 deficient MCF-7 cells by Dillenia suffruticosa root extract via multiple signalling pathways. BMC Complement Altern Med. 2014;14:1–16. doi: 10.1186/1472-6882-14-197. PubMed DOI PMC

Arulnathan SB, Leong KH, Ariffin A, Kareem HS, Cheah KKH. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line. Anticancer Agents Med Chem. 2020;20:1072–1086. doi: 10.2174/1871520620666200318100051. PubMed DOI